Khawaja, Muzamil
Thakker, Janki
Kherallah, Riyad
Kitakaze, Masafumi
Jneid, Hani
Angiolillo, Dominick J.
Birnbaum, Yochai http://orcid.org/0000-0001-7653-6328
Funding for this research was provided by:
John S. Dunn Foundation
Article History
Accepted: 13 June 2022
First Online: 18 June 2022
Declarations
:
: This is a review article. No ethical approval is required.
: Not applicable.
: All authors read and approved the final manuscript, submitted for consideration of publication in <i>Cardiovascular Drugs and Therapy</i>.
: Hani Jneid: no relevant financial or non-financial interests to disclose.Masafumi Kitakaze: research grant from Takeda; speaker honoraria from AstraZeneca, Ono, Novartis, Tanabe-Mitsubishi, Takeda, Pfizer, Daiichi-Sankyo, Otsuka, Sanofi, Boehringer Ingelheim, Amgen, Kowa, Toyama-Kagaku, and Kureha.Dominick J. Angiolillo: consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PhaseBio, PLx Pharma, Pfizer, Sanofi, and The Medicines Company and has received payments for participation in review activities from CeloNova and St Jude Medical, outside the present work. He also declares that his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions, and Scott R. MacKenzie Foundation.Yochai Birnbaum: research grant from AstraZeneca.Muzamil Khawaja: no relevant financial or non-financial interests to disclose.Janki Thakker: no relevant financial or non-financial interests to disclose.Riyad Kherallah: no relevant financial or non-financial interests to disclose.